FDA Approves Solriamfetol Hydrochloride by Alkem Labs
The FDA has approved Solriamfetol Hydrochloride under application ANDA218722 submitted by Alkem Labs.
Company
Pharmaceutical intelligence for Alkem Labs with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No signals indexed for this entity yet.
No signals indexed for this entity yet.
No signals indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.